Epoprostenol in pregnant patients with secondary pulmonary hypertension: Two case reports and a review of the literature

Treatments in Respiratory Medicine

Volumn 3, Issue 1, 2004, Pages 29-34

  Avdalovic, Mark ^a   Sandrock, Christian ^a   Hoso, Andrea ^a   Allen, Roblee ^a   Albertson, Timothy E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DIGOXIN; HEPARIN; PROSTACYCLIN; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; CHILDBIRTH; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FILIPINO; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART OUTPUT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MORTALITY; PATHOPHYSIOLOGY; PATIENT CARE; PHYSICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VAGINAL DELIVERY;

ADULT; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; HYPERTENSION, PULMONARY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 1842608806     PISSN: 11763450     EISSN: None     Source Type: Journal    
DOI: 10.2165/00151829-200403010-00004     Document Type: Article

References (38)

1. Weiss BM, Hess OM. Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 2000; 21: 104-15
2. James KB. Heart disease arising during pregnancy. In: Douglas PS, editor. Cardiovascular health and disease in women. Philadelphia (PA): Saunders, 1993: 332-41
3. Vongpatanasin W, Brickner ME, Hillis LD, et al. The Eisenmenger syndrome in adults. Ann Intern Med 1998; 128: 745-55
4. Craig RJ, Selzer A. Natural history and prognosis of atrial septal defect. Circulation 1968; 37: 805-15
5. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults: First of two parts. N Engl J Med 2000; 342 (4): 256-63
6. Vogel M, Berger F, Kramer A, et al. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 1999; 82 (1): 30-3
7. Peacock AJ. Primary pulmonary hypertension. Thorax 1999; 54: 1107-18
8. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336: 111-7
9. Rich S, editor. Primary pulmonary hypertension: Executive summary from the world symposium. Geneva: World Health Organization, 1998
10. Galie N, Manes A, Uguccioni L, et al. Primary pulmonary hypertension: Insights into pathogenesis from epidemiology. Chest 1998; 114: 184S-94S
11. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension [published erratum appears in N Engl J Med 2002; 16: 1258]. N Engl J Med 2002; 12: 896-903
12. Sullivan CC, Du L, Chu D, et al. Induction of pulmonary hypertension by an angiopoietin I/TIE2/serotonin pathway. Proc Natl Acad Sci U S A 2003; 21: 12331-6
13. Du L, Sullivan CC, Chu D, et al. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 2003; 6: 500-9
14. Salvi SS. Alpha 1-adrenergic hypothesis for pulmonary hypertension. Chest 1999; 115: 1708-19
15. Simonneau G, Fartoukh M, Sitbon O, et al. Primary pulmonary hypertension associated with the use of fenfluramine derivatives. Chest 1998; 114: 195S-9S
16. Weir EK, Reeve HL, Johnson G, et al. A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension. Chest 1998; 114: 200S-4S
17. Hopkins WE, Ochoa LL, Richardson GW, et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996; 15 (1 Pt 1): 100-5
18. Hopkins WE, Waggoner AD. Severe pulmonary hypertension without right ventricular failure: The unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 2002; 89 (1): 34-8
19. Yi ES, Kim H, Ahn H, et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension: A morphometric and immunohistochemical study. Am J Respir Crit Care Med 2000; 162 (4 Pt 1): 1577-86
20. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996; 334: 296-302
21. Rubin LJ, Mendoza J, Hood M, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): Results of a randomized trial. Ann Intern Med 1990; 112: 485-91
22. McLaughlin VV, Genthner DE, Panella MM, et al. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998; 338: 273-7
23. Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999; 99 (14): 1858-65
24. Rubin LJ. Therapy of pulmonary hypertension: The evolution from vasodilators to antiproliferative agents. Am J Respir Crit Care Med 2002; 166 (10): 1308-9
25. Clapp III JF, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997; 80: 1469-73
26. Meyer NL, Mercer B, Khoury A, et al. Pregnancy complicated by cardiac disease: Maternal and perinatal outcome. J Matern Fetal Med 1994; 3: 31-6
27. Siu SC, Colman JM. Heart disease and pregnancy. Heart 2001; 85: 710-5
28. McFaul PB, Dornan JC, Lamki H, et al. Pregnancy complicated by maternal heart disease: A review of 519 women. Br J Obstet Gynaecol 1988; 95: 861-7
29. Weiss BM, Zemp L, Seifert B, et al. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31: 1650-7
30. Gleicher N, Midwall J, Hochberger D, et al. Eisenmenger's syndrome and pregnancy. Obstet Gynecol Surv 1979; 34: 721-41
31. Yentis SM, Steer PJ, Plaat F. Eisenmenger's syndrome in pregnancy: Maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 1998; 105: 921-2
32. Avila WS, Grinberg M, Snitcowsky R, et al. Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome. Eur Heart J 1995; 16: 460-4
33. Mukhtar AI, Halliday HL. Eisenmenger syndrome in pregnancy: A possible cause of neonatal polycythemia and persistent fetal circulation. Obstet Gynecol 1982; 60: 651-2
34. Goodwin TM, Gherman RB, Hameed A, et al. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol 1999; 180: 64-7
35. Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome: Factors relating to deterioration and death. Eur Heart J 1998; 19: 1845-55
36. McLaughlin VV, Genthner DE, Panella MM, et al. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: A case series. Ann Intern Med 1999; 130: 740-3
37. Lust KM, Boots RJ, Dooris M, et al. Management of labor in Eisenmenger syndrome with inhaled nitric oxide. Am J Obstet Gynecol 1999; 181: 419-23
38. Smedstad KG, Cramb R, Morison DH. Pulmonary hypertension and pregnancy: A series of eight cases. Can J Anaesth 1994; 41: 502-12